NASDAQ: NEO
Neogenomics Inc Stock Ownership - Who owns Neogenomics?

Insider buying vs selling

Have Neogenomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynn A. TetraultDirector2026-06-155,307$11.10
$58.91kSell
Lynn A. TetraultDirector2026-06-095,307$11.29
$59.92kSell
Warren StonePres Chief Operating Officer2026-01-2022,128$12.50
$276.69kSell
Alicia C. OlivoEVP GC Business Development2025-11-258,977$10.05
$90.22kBuy
Alicia C. OlivoEVP GC Business Development2025-11-2520,916$12.00
$250.99kSell
Alicia C. OlivoEVP GC Business Development2025-10-164,918$10.00
$49.18kSell
Jeffrey Scott ShermanChief Financial Officer2025-08-0620,000$5.62
$112.32kBuy
Anthony P. ZookChief Executive Officer2025-08-0617,900$5.58
$99.95kBuy

1 of 1

NEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NEO insiders and whales buy or sell their stock.

NEO Shareholders

What type of owners hold Neogenomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.53%19,957,502$304.75MInstitution
Electric Co General11.68%15,000,000$229.05MInsider
First Light Asset Management LLC7.57%9,729,978$148.58MInstitution
Greenhouse Funds LLLP7.08%9,100,103$138.96MInstitution
Peter M. Peterson6.38%8,202,050$125.25MInsider
Vanguard Portfolio Management LLC5.93%7,622,187$116.39MInstitution
Steven C. Jones5.75%7,393,510$112.90MInsider
First Trust Advisors LP4.80%6,162,371$94.10MInstitution
Vanguard Capital Management LLC4.40%5,655,823$86.36MInstitution
Braidwell LP4.37%5,617,402$85.78MInstitution

1 of 3

NEO vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NEO73.34%26.66%Net SellingNet Selling
CDNA77.21%22.79%Net SellingNet Selling
NEOG97.92%2.08%Net BuyingNet Buying
PSNL69.77%30.23%Net BuyingNet Buying
FRNM9.46%24.63%Net BuyingNet Buying

Neogenomics Stock Ownership FAQ

Who owns Neogenomics?

Neogenomics (NASDAQ: NEO) is owned by 104.41% institutional shareholders, 37.94% Neogenomics insiders, and 0.00% retail investors. Electric Co General is the largest individual Neogenomics shareholder, owning 15.00M shares representing 11.68% of the company. Electric Co General's Neogenomics shares are currently valued at $238.20M.

If you're new to stock investing, here's how to buy Neogenomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.